Name: Stoke Therapeutics, Inc. (STOK) Balance Sheet
Creator: FinSpry

Stoke Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Stoke Therapeutics, Inc. (STOK) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	127.98	201.39	113.56	219.81	287.31
Short-Term Investments	88.92	9.95	116.04	74.92	0.00
Cash & Short-Term Investments	216.90	201.39	229.60	219.81	287.31
Accounts Receivable	0.70	0.06	0.59	0.13	0.01
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	15.16	2.56	10.93	2.22	6.44
Total Current Assets	232.76	215.34	244.07	229.22	293.93
Non-Current Assets
Property, Plant & Equipment (Net)	8.25	12.43	11.43	9.08	3.79
Long-Term Investments	29.82	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.72	0.57	0.57	0.57	0.21
Total Non-Current Assets	38.80	13.00	12.00	9.65	4.00
Total Assets	271.56	228.34	256.07	238.87	297.93
Current Liabilities
Accounts Payable	2.50	1.70	0.77	2.39	1.50
Short-Term Debt	2.32	0.00	0.00	0.00	0.00
Accrued Liabilities	7.81	10.90	12.88	12.71	8.41
Deferred Revenue	18.99	15.31	14.88	0.00	0.00
Other Current Liabilities	16.25	13.82	0.51	14.75	9.93
Total Current Liabilities	40.06	30.82	31.39	17.14	11.43
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	2.48	4.88	0.25	3.95	0.34
Total Non-Current Liabilities	2.48	37.96	39.82	3.95	0.42
Total Liabilities	42.53	68.78	71.22	21.09	11.85
Stockholders' Equity
Common Stock	0.01	0.01	0.00	0.00	0.00
Retained Earnings	-490.83	-401.87	-297.15	-196.25	-110.28
Accumulated Other Comprehensive Income	-0.15	-0.02	-1.18	-0.17	0.00
Additional Paid-in Capital	720.00	561.43	483.17	414.02	396.35
Shares Outstanding	54.03	45.92	39.44	36.90	0.00
Total Stockholders' Equity	229.02	159.57	184.85	217.78	286.08
Total Liabilities & Equity	271.56	228.34	256.07	238.87	297.93